[3H]MRS 1754, a selective antagonist radioligand for A2B adenosine receptors

被引:81
|
作者
Ji, XD
Kim, YC
Ahern, DG
Linden, J
Jacobson, KA
机构
[1] NIDDKD, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA
[2] NEN Life Sci Prod, Boston, MA 02118 USA
[3] Univ Virginia, Hlth Sci Ctr, Dept Internal Med & Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA
关键词
G protein-coupled receptors; tritium purines; xanthines; adenosine analogues;
D O I
10.1016/S0006-2952(01)00531-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
MRS 1754 [N-(4-cyanophenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-phenoxy]acetamide] is a selective antagonist ligand of A(2B) adenosine receptors. This is the least well-defined adenosine receptor subtype, and A(2B) antagonists have potential as antiasthmatic drugs. For use as a radioligand, MRS 1754, a p-cyanoanilide xanthine derivative, was tritiated on the propyl groups in a two-step reaction using a p-carboxamido precursor, which was dehydrated to the cyano species using trifluoroacetic anhydride. [H-3]MRS 1754 (150 Ci/mmol) bound to recombinant human A(2B) adenosine receptors in membranes of stably transfected HEK-293 cells. Specific binding was saturable, competitive, and followed a one-site model, with a K-D value of 1.13 +/- 0.12 nM and a B-max value of 10.9 +/- 0.6 pmol/mg protein. Specific binding utilizing 0.7 nM [H-3]MRS 1754 was > 70% of total binding. The affinity calculated from association and dissociation binding constants was 1.22 nM (N = 4). Binding to membranes expressing rat and human A(1) and A(3), adenosine receptors was not significant, and binding in membranes of HEK-293 cells expressing human A(2A) receptors was of low affinity (K-D > 50 nM). The effects of cations and chelators were explored. Specific binding was constant over a pH range of 4.5 to 6.5, with reduced binding at higher pH. The pharmacological profile in competition experiments with [H-3]MRS 1754 was consistent with the structure-activity relationship for agonists and antagonists at A(2B) receptors. The K-i values of XAC (xanthine amine congener) and CPX (8-cyclopentyl-1,3-diproplylxanthine) were 16 and 55 nM, respectively. NECA (5'-N-ethylcarboxamidoadenosine) competed for [H-3]MRS 1754 binding with a K-i of 570 nM, similar to its potency in functional assays. Thus, [H-3]MRS 1754 is suitable as a selective, high-affinity radioligand for A(2B) receptors. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:657 / 663
页数:7
相关论文
共 50 条
  • [41] Heteromeric association of A2A and A2B adenosine receptors
    Feoktistov, I
    Ryzhov, S
    Goldstein, AE
    Biaggioni, I
    DRUG DEVELOPMENT RESEARCH, 2002, 56 (04) : 574 - 574
  • [42] Characterization of [3H]PSB-0413, the first selective radioligand for P2Y12 receptors
    Abdelrahman, Aliaa
    Atzler, Kerstin
    El-Tayeb, Ali
    Mueller, Christa E.
    PURINERGIC SIGNALLING, 2010, 6 (01) : 69 - 70
  • [43] [3H]SCH 58261, a selective adenosine A2A receptor antagonist, is a useful ligand in autoradiographic studies
    Fredholm, BB
    Lindström, K
    Dionisotti, S
    Ongini, E
    JOURNAL OF NEUROCHEMISTRY, 1998, 70 (03) : 1210 - 1216
  • [44] [3H]UR-PLN196: A Selective Nonpeptide Radioligand and Insurmountable Antagonist for the NeuropeptideY Y2Receptor
    Pluym, Nikola
    Baumeister, Paul
    Keller, Max
    Bernhardt, Guenther
    Buschauer, Armin
    CHEMMEDCHEM, 2013, 8 (04) : 587 - 593
  • [45] [3H]Rauwolscine:: an antagonist radioligand for the cloned human 5-hydroxytryptamine2B (5-HT2B) receptor
    Wainscott, DB
    Sasso, DA
    Kursar, JD
    Baez, M
    Lucaites, VL
    Nelson, DL
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (01) : 17 - 24
  • [46] Synthesis and preliminary biological evaluation of [3H]-MRE 3008-F20:: the first high affinity radioligand antagonist for the human A3 adenosine receptors
    Baraldi, PG
    Cacciari, B
    Romagnoli, R
    Varani, K
    Merighi, S
    Gessi, S
    Borea, PA
    Leung, E
    Hickey, SL
    Spalluto, G
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (03) : 209 - 211
  • [47] Selective A3 Adenosine Receptor Antagonist Radioligand for Humanand Rodent Species
    Suresh, R. Rama
    Gao, Zhan-Guo
    Salmaso, Veronica
    Chen, Eric
    Campbell, Ryan G.
    Poe, Russell B.
    Liston, Theodore E.
    Jacobson, Kenneth A.
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (04): : 623 - 631
  • [48] The Selective Adenosine 2B Receptor Antagonist MRS1754 Mitigates Hepatic Collagen Deposition During Fibrosis Progression and Induces Mild Fibrosis Regression
    Stoll, Matthias
    Kim, Yong Ook
    Hebich, Bernhard
    Robson, Simon C.
    Schuppan, Detlef
    GASTROENTEROLOGY, 2012, 142 (05) : S974 - S975
  • [49] A2A and A2B adenosine receptors: The extracellular loop 2 determines high (A2A) or low affinity (A2B) for adenosine
    De Filippo, Elisabetta
    Hinz, Sonja
    Pellizzari, Veronica
    Deganutti, Giuseppe
    El-Tayeb, Ali
    Navarro, Gemma
    Franco, Rafael
    Moro, Stefano
    Schiedel, Anke C.
    Mueller, Christa E.
    BIOCHEMICAL PHARMACOLOGY, 2020, 172
  • [50] Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist
    Eastwood, Paul
    Esteve, Cristina
    Gonzalez, Jacob
    Fonquerna, Silvia
    Aiguade, Josep
    Carranco, Ines
    Domenech, Teresa
    Aparici, Monica
    Miralpeix, Montserrat
    Alberti, Joan
    Cordoba, Monica
    Fernandez, Raquel
    Pont, Merce
    Godessart, Nuria
    Prats, Neus
    Isabel Loza, Maria
    Isabel Cadavid, Maria
    Nueda, Arsenio
    Vidal, Bernat
    ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (03): : 213 - 218